Previous 10 | Next 10 |
Looking For The Best Biotech Stocks For Your Watchlist? 3 Names To Know While many investors would agree that 2020 was the year for biotech stocks to shine, we may be able to say the same for 2021. The industry continues to bring huge gains for investors. Evidently, we see this ...
With the stock up 189% year-to-date, including a 74% moonshot yesterday after data from the Phase 1 trial of the company's chronic hepatitis B treatment, JPMorgan's Anupam Rama downgrades Vir Biotech (VIR) to Underweight from Neutral.He trims his price target to $28 from $30, and vs. yesterda...
Eli Lilly (LLY), Vir Biotechnology (VIR) and GlaxoSmithKline (GSK) have collaborated to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to moderate symptoms.Lilly has expanded its ongoing BLAZE-4 trial to evaluate bamlanivimab (LY-CoV555) 700mg with VIR-78...
INDIANAPOLIS, SAN FRANCISCO and LONDON, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients...
Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19 PR Newswire INDIANAPOLIS and SAN FRANCISCO and LONDON , Jan. 27, 2021 /PRNewswire/ -- Eli L...
Gainers: [[BBBY]] +17.7%. [[IMMP]] +15.8%. [[FHTX]] +7.6%. [[TLSA]] +6.8%. [[ADMS]] +6.8%.Losers: [[TTOO]] -20.3%. [[VIR]] -17.0%. [[GRTX]] -16.6%. [[AGIO]] -8.4%. [[WMG]] -7.7%. For further details see: BBBY, IMMP, TTOO and VIR among after-hours movers
Shares of Vir Biotechnology (NASDAQ: VIR) soared 74% on Tuesday after the immunology company released promising results from an early-stage study of its experimental antibody treatment for the hepatitis B virus (HBV). Preliminary data from Vir Biotechnology's phase 1 trial o...
Gainers: Oxbridge Re (OXBR) +62%.Koss (KOSS) +60%.AIkido Pharma (AIKI) +51%.Vertex Energy (VTNR) +56%.Phunware (PHUN) +45%.Edesa Biotech (EDSA) +33%.CarParts.com (PRTS) +32%.Workhorse Group (WKHS) +30%.Orbital Energy (OEG) +27%.Vir Biotechnology (VIR) +27%.Losers: Express ...
Vir Biotechnology ([[VIR]] +40.0%) has announced initial data from its ongoing Phase 1 trial of VIR-3434 in patients with chronic hepatitis B virus ((HBV)) infection. The HBV-neutralizing monoclonal antibody designed to block entry of all 10 genotypes of HBV into hepatocytes and red...
– Novel HBV-neutralizing monoclonal antibody with therapeutic vaccine potential demonstrated a mean HBsAg reduction from baseline of 1.3 log10 IU/mL by day eight – SAN FRANCISCO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced initia...
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology Inc. Company Name:
VIR Stock Symbol:
NASDAQ Market:
Vir Biotechnology Inc. Website:
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, 2024, on August 1, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on August 1, 2024. Financial results will ...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
2024-07-08 10:47:03 ET BITX (BITX) BITX is trading DOWN for the last 4 days, and it at trading at $27.48 with volume of 3,908,355 and a one day change of $-0.37 (-1.33%). BITX has a 52-week low of 0.00 and a 52-week high of $0.00. The business's 50-day moving average price is $45.40...